CD274 and neoplasm: To further determine whether sequential administration of low-dose TSA and PD-L1 blockade can improve T cell-mediated anti-tumor immunity by modulating the suppressive activity of infiltrating myeloid cells, we subsequently explored changes in T cell infiltration of tumors.